clinical trial · NCT07546214
A Study Comparing Tapinarof Cream 1% and Vtama® Cream 1% in the Treatment of Plaque Psoriasis.
Sun Pharmaceutical Industries, Inc.·phase1·completed·n = 575
Plaque PsoriasisTapinarof Cream, 1%Vtama® (Tapinarof) Cream, 1%Placebo Control
brief summary
To demonstrate therapeutic equivalence and safety of Tapinarof Cream, 1% (Sun pharma Canada, Inc.) and Vtama® (Tapinarof) Cream, 1% in the treatment of plaque psoriasis.
started
Oct 13, 2025
primary completion
Mar 18, 2026
completion
Mar 18, 2026
last updated
Apr 22, 2026
detailed description
A multi-center, double-blind, randomized, placebo-controlled, parallel-group study, comparing Tapinarof Cream, 1% (Sun pharma Canada, Inc.) and Vtama® (Tapinarof) Cream, 1% in the treatment of plaque psoriasis.
official title
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study, Comparing Tapinarof Cream, 1% (Sun Pharma Canada, Inc.) and Vtama® (Tapinarof) Cream, 1% in the Treatment of Plaque Psoriasis.
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol